advertisement
Multiple Myeloma News
July 24, 2023

Top Headlines

advertisement

Latest Headlines
updated 12:57pm EDT

Earlier Headlines

Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T

Researchers have identified therapies that can help patients with the blood cancer multiple myeloma who try an immunotherapy known as CAR-T only to find their cancer coming back ...

Achilles’ Heel of High-Risk Multiple Myeloma

Chromosomal abnormalities are found in most multiple myeloma (MM) patients. While myeloma patients have generally benefited from the advancement of treatment modalities over the years, the treatment ...

Third Dose of COVID-19 Vaccine Significantly Increases Immune Responses in Most Patients With Multiple Myeloma

Most immunocompromised people with a blood cancer called multiple myeloma benefited from a third dose of COVID-19 vaccines, a promising sign after it was shown that two doses tended to not be ...

Potential New CAR-T Cell Therapy for Multiple Myeloma

Researchers are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple ...

New Epigenetic Regulatory Mechanisms Involved in Multiple Myeloma Growth

An international team of researchers has analyzed the function of the histone demethylase KDM5A in multiple myeloma, one of the three major hematological cancers, and clarified the mechanism by which ...

Personalized Cancer Vaccine Deemed Safe, Shows Potential Benefit Against Cancer

A personalized cancer vaccine raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to ...

advertisement

Glitch in Genome Architecture May Cause B-Cell Malignancies

Restoring an enzyme that maintains the way chromosomes are packed inside cells may lead to new therapies for some blood cancers, according to a new ...

设计师DNA治疗癌症干细胞玻璃纸擦拭ls, Treats Multiple Myeloma in Mice

A new study supports launch of Phase I clinical trial to test a designer DNA agent -- an antisense oligonucleotide that targets a gene called IRF4 -- in patients with multiple ...

Off-the-Shelf Immune Drug Shows Promise in Aggressive Multiple Myeloma

A subcutaneous injection of the immune-boosting drug teclistamab was found to be safe and elicit responses in a majority of patients with relapsed or refractory multiple ...